Company Registration No. 08391968 (England and Wales)
THE SURGERY DESIGN AND DIGITAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
The Granary
Hones Yard
1 Waverley Lane
Farnham
Surrey
GU9 8BB
THE SURGERY DESIGN AND DIGITAL LIMITED
CONTENTS
Page
Company information
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 10
THE SURGERY DESIGN AND DIGITAL LIMITED
COMPANY INFORMATION
- 1 -
Directors
Mr P. Cohen
Mr N. Cordell
Company number
08391968
Registered office
Granary Barn
Orchard Park Farm
Lurgashall
Petworth
GU28 9EU
Accountants
TC Group
The Granary
Hones Yard
1 Waverley Lane
Farnham
Surrey
GU9 8BB
THE SURGERY DESIGN AND DIGITAL LIMITED
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 2 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
4
31,280
42,972
Current assets
Stocks
17,563
56,298
Debtors
5
316,924
381,408
Cash at bank and in hand
47,087
174,253
381,574
611,959
Creditors: amounts falling due within one year
6
(244,042)
(345,301)
Net current assets
137,532
266,658
Total assets less current liabilities
168,812
309,630
Creditors: amounts falling due after more than one year
7
(11,720)
(21,301)
Provisions for liabilities
(7,820)
(10,743)
Net assets
149,272
277,586
Capital and reserves
Called up share capital
300
300
Profit and loss reserves
148,972
277,286
Total equity
149,272
277,586
THE SURGERY DESIGN AND DIGITAL LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2024
31 March 2024
- 3 -

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 22 October 2024 and are signed on its behalf by:
Mr P. Cohen
Director
Company Registration No. 08391968
The notes on pages 4 to 10 form part of these financial statements
THE SURGERY DESIGN AND DIGITAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 4 -
1
Accounting policies
Company information

The Surgery Design and Digital Limited (08391968) is a private company limited by shares incorporated in England and Wales. The registered office is Granary Barn, Orchard Park Farm, Lurgashall, Petworth, GU28 9EU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
15% Straight Line
Motor vehicles
25% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

THE SURGERY DESIGN AND DIGITAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 5 -

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

THE SURGERY DESIGN AND DIGITAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 6 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred taxation is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accounting purposes. The deferred tax balance has not been discounted.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.11
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.12
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

THE SURGERY DESIGN AND DIGITAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 7 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
19
16
3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2023 and 31 March 2024
6,000
Amortisation and impairment
At 1 April 2023 and 31 March 2024
6,000
Carrying amount
At 31 March 2024
-
0
At 31 March 2023
-
0
THE SURGERY DESIGN AND DIGITAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 8 -
4
Tangible fixed assets
Fixtures, fittings & equipment
Motor vehicles
Total
£
£
£
Cost
At 1 April 2023
68,474
12,736
81,210
Additions
2,232
-
0
2,232
Disposals
(14,148)
-
0
(14,148)
At 31 March 2024
56,558
12,736
69,294
Depreciation and impairment
At 1 April 2023
30,203
8,035
38,238
Depreciation charged in the year
7,286
1,175
8,461
Eliminated in respect of disposals
(8,685)
-
0
(8,685)
At 31 March 2024
28,804
9,210
38,014
Carrying amount
At 31 March 2024
27,754
3,526
31,280
At 31 March 2023
38,271
4,701
42,972
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
205,552
301,615
Amounts owed by group undertakings
51,400
-
0
Other debtors
54,429
67,628
Prepayments and accrued income
5,543
12,165
316,924
381,408
THE SURGERY DESIGN AND DIGITAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 9 -
6
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
8,000
8,000
Trade creditors
20,152
62,948
Taxation and social security
209,458
265,580
Other creditors
6,432
8,773
244,042
345,301
7
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Bank loans
10,621
18,564
Obligations under finance leases
1,099
2,737

Liabilities relating to hire purchase contracts are secured over the assets to which they relate.

8
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2024
2023
£
£
32,900
52,000
9
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

Purchases
2024
2023
£
£
Management charges
25,000
-
THE SURGERY DESIGN AND DIGITAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
9
Related party transactions
(Continued)
- 10 -

The following amounts were outstanding at the reporting end date:

2024
2023
Amounts due to related parties
£
£
Entities with control, joint control or significant influence over the company
51,400
-
10
Directors' transactions

The directors maintain loan accounts with the company. At the start of the year, the directors owed the company £61,028. During the year, the directors were further advanced £176,950 and repayments were received totalling £191,703. Interest was charged on the overdrawn balance at 2.25%. At the balance sheet date, the directors owed the company £46,715.

2024-03-312023-04-01false22 October 2024CCH SoftwareCCH Accounts Production 2024.210No description of principal activityMr P. CohenMr N. Cordellfalsefalse083919682023-04-012024-03-3108391968bus:Director12023-04-012024-03-3108391968bus:Director22023-04-012024-03-3108391968bus:RegisteredOffice2023-04-012024-03-31083919682024-03-31083919682023-03-3108391968core:FurnitureFittings2024-03-3108391968core:MotorVehicles2024-03-3108391968core:FurnitureFittings2023-03-3108391968core:MotorVehicles2023-03-3108391968core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3108391968core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3108391968core:CurrentFinancialInstruments2024-03-3108391968core:CurrentFinancialInstruments2023-03-3108391968core:Non-currentFinancialInstruments2024-03-3108391968core:Non-currentFinancialInstruments2023-03-3108391968core:ShareCapital2024-03-3108391968core:ShareCapital2023-03-3108391968core:RetainedEarningsAccumulatedLosses2024-03-3108391968core:RetainedEarningsAccumulatedLosses2023-03-3108391968core:FurnitureFittings2023-04-012024-03-3108391968core:MotorVehicles2023-04-012024-03-31083919682022-04-012023-03-3108391968core:NetGoodwill2023-03-3108391968core:NetGoodwill2024-03-3108391968core:NetGoodwill2023-03-3108391968core:FurnitureFittings2023-03-3108391968core:MotorVehicles2023-03-31083919682023-03-3108391968core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2024-03-3108391968bus:PrivateLimitedCompanyLtd2023-04-012024-03-3108391968bus:SmallCompaniesRegimeForAccounts2023-04-012024-03-3108391968bus:FRS1022023-04-012024-03-3108391968bus:AuditExemptWithAccountantsReport2023-04-012024-03-3108391968bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP